ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,671.06
      1.35%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Leap Therapeutics Inc (LPTX)

      7. Leap Therapeutics Inc (LPTX) News

      LPTX

      Leap Therapeutics (LPTX)

      Leap Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPTX
      DateTimeSourceHeadlineSymbolCompany
      11/13/20237:00AMPR Newswire (US)Leap Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      11/13/20236:51AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
      09/13/20232:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
      09/05/20237:00AMPR Newswire (US)Leap Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:LPTXLeap Therapeutics Inc
      08/30/20234:30PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/25/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
      08/14/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
      08/14/20237:00AMPR Newswire (US)Leap Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      08/14/20236:50AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
      07/12/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
      07/12/20237:00AMPR Newswire (US)Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer PatientsNASDAQ:LPTXLeap Therapeutics Inc
      06/20/202312:30PMPR Newswire (US)Leap Therapeutics Announces Reverse Stock SplitNASDAQ:LPTXLeap Therapeutics Inc
      06/15/20236:26AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LPTXLeap Therapeutics Inc
      06/14/20234:32PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LPTXLeap Therapeutics Inc
      06/09/20234:11PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:LPTXLeap Therapeutics Inc
      05/25/20235:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      05/25/20235:10PMPR Newswire (US)Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual MeetingNASDAQ:LPTXLeap Therapeutics Inc
      05/15/20237:07AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LPTXLeap Therapeutics Inc
      05/15/20237:00AMPR Newswire (US)Leap Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
      05/15/20236:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
      04/28/20234:23PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LPTXLeap Therapeutics Inc
      04/28/20234:21PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LPTXLeap Therapeutics Inc
      04/26/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LPTXLeap Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LPTX

      Your Recent History

      BIT
      UC3S7X
      Unicredit Bank
      Delayed Upgrade Clock